These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1764 related articles for article (PubMed ID: 26811668)

  • 1. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
    Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
    Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
    Chen HN; Wang Z; Li X; Zhou ZG
    Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
    Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development.
    Watari J; Chen N; Amenta PS; Fukui H; Oshima T; Tomita T; Miwa H; Lim KJ; Das KM
    World J Gastroenterol; 2014 May; 20(18):5461-73. PubMed ID: 24833876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].
    Muller LB; Fagundes RB; Moraes CC; Rampazzo A
    Arq Gastroenterol; 2007; 44(2):93-8. PubMed ID: 17962851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of
    Lahner E; Carabotti M; Annibale B
    World J Gastroenterol; 2018 Jun; 24(22):2373-2380. PubMed ID: 29904244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of Helicobacter pylori infection and eradication on proliferative kinetics of the gastric mucosa].
    Unger Z; Prónai L; Szaleczky E; Zágoni T; Molnár B; Tulassay Z
    Orv Hetil; 2000 Dec; 141(50):2695-700. PubMed ID: 11189675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
    Kim N
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.
    Valenzuela MA; Canales J; Corvalán AH; Quest AF
    World J Gastroenterol; 2015 Dec; 21(45):12742-56. PubMed ID: 26668499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future candidates for indications of Helicobacter pylori eradication: do the indications need to be revised?
    Lee SY
    J Gastroenterol Hepatol; 2012 Feb; 27(2):200-11. PubMed ID: 22098099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up.
    Kim N; Park RY; Cho SI; Lim SH; Lee KH; Lee W; Kang HM; Lee HS; Jung HC; Song IS
    J Clin Gastroenterol; 2008; 42(5):448-54. PubMed ID: 18344895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Helicobacter pylori in gastric carcinoma.
    Prabhu SR; Amrapurkar AD; Amrapurkar DN
    Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
    J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of
    Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
    Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenesis of Helicobacter pylori.
    Correa P; Houghton J
    Gastroenterology; 2007 Aug; 133(2):659-72. PubMed ID: 17681184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
    Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
    Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
    Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
    Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.